The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
Written by
in
The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.
Written by
in